Navigation Links
MELA Sciences, Inc., A Leader In The Fight Against Melanoma, Hosts Symposium At 8th World Congress Of Melanoma
Date:7/22/2013

rmation that may be used by dermatologists in the biopsy decision-making process. MelaFind® has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind® has received CE Mark approval and is approved for use in the European Union.

For more information on MELA Sciences, visit www.melasciences.com.

Safe Harbor:
This press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995. These statements include but are not limited to our plans, objectives, expectations and intentions and other statements that contain words such as "expects," "contemplates," "anticipates," "plans," "intends," "believes," "assumes," "predicts" and variations of such words or similar expressions that predict or indicate future events or trends, or that do not relate to historical matters. These statements are based on our current beliefs or expectations and are inherently subject to significant known and unknown uncertainties and changes in circumstances, many of which are beyond our control. There can be no assurance that our beliefs or expectations will be achieved. Actual results may differ materially from our beliefs or expectations due to financial, economic, business, competitive, market, regulatory and political factors or conditions affecting the company and the medical device industry in general, as well as more specific risks and uncertainties facing the company such as those set forth in its reports on Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission (the "SEC"). Factors that might cause such a difference include whether MelaFind® achieves market acceptance. Given the uncertainties affecting companies in the medical device industry such as the Company, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking
'/>"/>

SOURCE MELA Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pressure BioSciences, Inc. to Present at the Marcum MicroCap Conference
2. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Ventrus Biosciences, Inc.
3. Pressure BioSciences, Inc. to Present at the SeeThruEquity Spring Investor Microcap Forum
4. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
5. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
6. Pressure BioSciences, Inc. to Discuss Third Quarter 2012 Financial Results and Provide Business Update
7. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
8. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
9. QPS Acquires JSW Life Sciences, Largest Independent Contract Research Organization in Austria
10. Pressure BioSciences, Inc. Reports 70% Revenue Growth for Second Consecutive Quarter
11. Pressure BioSciences, Inc. to Discuss Second Quarter 2012 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: Insulin ... http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining strong ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... market research report is available in ... Global Markets and Technologies for Advanced ... Routes of Administration ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16
... , , , CARLSBAD, Calif., ... today its intention to file a Special Protocol Assessment (SPA) with ... on its lead drug, DCCR, for the treatment of very high ... primary efficacy endpoint assessed at 12 weeks. This decision followed ...
... , , , ... ANDS ) today announced viral load data for the final cohort of ... Company,s oral inducer of endogenous interferons that acts via the toll-like receptor ... other day over 10 days, the mean (+/-SEM) maximal decline in viral ...
Cached Medicine Technology:Essentialis to Submit SPA for Hypertriglyceridemia 2ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients 2ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients 3ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients 4ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients 5
(Date:4/24/2014)... of hematopoietic stem cells from cord blood ... from adults, HSCs isolated from cord blood (CB) ... hematological reconstitution when engrafted in children with hematological ... HSCs are present in single CB collections, limiting ... decades investigators have used a variety of strategies ...
(Date:4/24/2014)... better understanding of drug interactions, which are a major ... two or more medications are taken at the same ... the other. Similarly, one drug may magnify the ... major cause of illness and hospitalization. However, there ... drug studies in humans. Limits come in part ...
(Date:4/24/2014)... patients before, during and after colorectal surgery cut hospital ... to researchers who led a study of the approach ... recovery, is easier on patients before surgery, doing away ... typically prescribed. After surgery, patients are encouraged to eat ... faster recoveries. , Among findings published in the May ...
(Date:4/24/2014)... epidemic of prescription opioid overdose deaths was outlined yesterday ... by leaders of agencies in the U.S. Department of ... health care providers to expand their use of medications ... describes a number of misperceptions that have limited access ... how medications can be used in combination with behavior ...
(Date:4/24/2014)... University researcher has found a relationship between motor skill ... spectrum disorder in very young children. , The ... a direct relationship between motor skills and autism severity, ... should be included in treatment plans for young children ... OSU,s College of Public Health and Human Sciences. ...
Breaking Medicine News(10 mins):Health News:JCI online ahead of print table of contents for April 24, 2014 2Health News:JCI online ahead of print table of contents for April 24, 2014 3Health News:JCI online ahead of print table of contents for April 24, 2014 4Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Motor skill deficiencies linked to autism severity in new research 2
... PLC ), a company focused on innovative cardiac ... the three,and six month periods ended June 30, 2008., ... with,$1,932,000 in the second quarter of 2007. The net ... $0.02 per diluted share, compared to a net,loss of ...
... Quigley,Corporation (Nasdaq: QGLY ) today announced that Gerard ... who will be retiring from the Company on,September 5, ... a,member of the Board of Directors. Mr. Gleeson joined ... positions including,Corporate Controller of the Company since 2004., ...
... Aug. 6 China Healthcare,Acquisition Corp (Amex: ... Huadu,Environment Holding Pte, Ltd. ("EAHE") announced today that ... acquisition agreement for CHM to acquire,EAHE in exchange ... the,People,s Republic of China ("China"), Europe-Asia Huadu (Yixing),Environment ...
... useparticularly consumption of beeris declining in the US, according to ... The American Journal of Medicine . Researchers examined 50 ... but no change in alcohol use disorders. Americans are drinking ... has remained fairly constant. More people now report that they ...
... ACG is a team of former medical device sales executives who ... is designed to address the hospital,s current issues with a focus ... declining and it is imperative that savings increase on all hospital ... ...
... discrimination from their health care providers were less likely ... to a report in the August issue of ... the American Association for Cancer Research. , "We ... serious public health implications as we know that higher ...
Cached Medicine News:Health News:PLC Systems Reports Second Quarter 2008 Results 2Health News:PLC Systems Reports Second Quarter 2008 Results 3Health News:PLC Systems Reports Second Quarter 2008 Results 4Health News:PLC Systems Reports Second Quarter 2008 Results 5Health News:PLC Systems Reports Second Quarter 2008 Results 6Health News:The Quigley Corporation Names Gerard M. Gleeson to Succeed Retiring George J. Longo as Chief Financial Officer and Director 2Health News:China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd. 2Health News:China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd. 3Health News:China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd. 4Health News:China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd. 5Health News:China Healthcare Acquisition Corp Signs Definitive Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd. 6Health News:Alcohol consumption declining, according to results of new study 2Health News:Anderson Consulting Group (ACG) Announces "The Art of Hospital Negotiation" -- Strategies & Tactics for Materials Management Course Exclusively for Hospital Personnel 2Health News:Anderson Consulting Group (ACG) Announces "The Art of Hospital Negotiation" -- Strategies & Tactics for Materials Management Course Exclusively for Hospital Personnel 3Health News:Perceived discrimination affects screening rates 2
... proven to be a successful alternative ... knee arthroplasty with proper indications. The ... unicompartmental knee system developed to streamline ... latest conservative surgical techniques with the ...
... Knee CR system was designed to ... femoral joint has a recessed, deepened ... advancement of the patella, which has ... The anatomic groove promotes more normal ...
The Biopro Modular TKO implant is among the thinnest bone conserving Posterior Cruciate Ligament sparing knees available. It provides all the benefits of the Biopro TKO implant and gives the option o...
... PowerSuite™ holmium laser combines excellent cutting, ... virtually bloodless procedures. It is also ... gall bladder stones of all compositions, ... tool. Because its laser light is ...
Medicine Products: